Candriam Equities L Oncology Impact, V - Capitalisation
LU2425425506
Candriam Equities L Oncology Impact, V - Capitalisation/ LU2425425506 /
NAV 06.06.2024
Diff.+4,4501
Ertragstyp
Ausrichtung
Fondsgesellschaft
1.843,8000 GBP
+0,24%
thesaurierend
Aktien
weltweit
Candriam ▶
Kennzahlen und Performance in:
Alle Kurse in GBP
Tranchen
Titel
Ertragstyp
Rückn. Preis
1 Jahr
3 Jahre
Candriam Equities L Oncology Imp...
thesaurierend
2.402,3501
+8,18%
+4,99%
Candriam Equities L Oncology Imp...
thesaurierend
2.567,2300
+8,32%
+5,38%
Candriam Equities L Oncology Imp...
thesaurierend
207,7400
+4,62%
-5,87%
Candriam Equities L Oncology Imp...
thesaurierend
2.235,0200
+4,75%
+15,35%
Candriam Equities L Oncology Imp...
ausschüttend
1.611,9800
+7,83%
+3,98%
Candriam Equities L Oncology Imp...
thesaurierend
245,2300
+4,97%
+13,24%
Candriam Equities L Oncology Imp...
ausschüttend
236,2600
+6,82%
+1,10%
Candriam Equities L Oncology Imp...
ausschüttend
191,3900
+7,73%
+3,67%
Candriam Equities L Oncology Imp...
ausschüttend
20.691,0000
+2,80%
+0,83%
Candriam Equities L Oncology Imp...
thesaurierend
158,1100
+4,63%
+14,96%
Candriam Equities L Oncology Imp...
thesaurierend
2.113,1299
+5,61%
-3,17%
Candriam Equities L Oncology Imp...
thesaurierend
259,9500
+5,87%
+16,14%
Candriam Equities L Oncology Imp...
thesaurierend
207,1800
+4,19%
-6,98%
Candriam Equities L Oncology Imp...
thesaurierend
286,9900
+7,72%
+3,66%
Candriam Equities L Oncology Imp...
thesaurierend
194,0700
+5,49%
-
Candriam Equities L Oncology Imp...
thesaurierend
1.843,8000
+5,09%
-
Candriam Equities L Oncology Imp...
thesaurierend
2.875,2300
+7,38%
+3,61%
Candriam Equities L Oncology Imp...
thesaurierend
157,6200
-
-
Candriam Equities L Oncology Imp...
thesaurierend
273,5400
+6,37%
+0,73%
Performance
lfd. Jahr
+8,68%
6 Monate
+12,66%
1 Jahr
+5,09%
3 Jahre
-
5 Jahre
-
10 Jahre
-
seit Beginn
+23,54%
Jahr
2023
-4,28%